"Old School Days" on the Middle Border, 1849-1859: The Mary Payne Beard Letters

Autor: Soderbergh, Peter A., Beard, Mary Payne

Publikováno v: History of Education Quarterly, 1968 Dec 01. 8(4), 497-504.

Externí odkaz: https://www.jstor.org/stable/367541

Paroxysmal Kinesigenic Dyskinesia Presented Following Concussion

Autor: Norman Cottrill, Brian McCully, Mary Payne

Publikováno v: Journal of Movement Disorders, Vol 12, Iss 1, Pp 52-53 (2019)

Externí odkaz: https://doaj.org/article/2c20693e8bc940518782ad29691d1c8a

Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy

Autor: Mary Payne, Amy Saunders, Sean Loudin, Margaret A. Honein, Marianna Footo Linz, Jessica R. Haas, Dana Meaney-Delman

Publikováno v: J Pediatr

Neonatal withdrawal can be difficult to treat in infants with co-exposure to opiates and gabapentin. Because maternal self-report can underestimate exposures, we evaluated the effect of universal toxicology screening for gabapentin. Identification of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956b679980eedd38b61d04e9a53f9092
https://doi.org/10.1016/j.jpeds.2019.09.029

Prevalence and Duration of Post-Concussive Headaches in a Pediatric Sports Clinic: A Cross-sectional Study

Autor: Dipali P. Nemade, Norman Cottrill, Mary Payne

Publikováno v: Neurology. 98:S7.1-S7

ObjectiveWe aim to identify the potential risk factors associated with increased susceptibility for persistent post-concussive headaches.BackgroundConcussions are common, but complex, traumatic brain injuries seen in pediatric athletes of all ages &

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84bb77598a5b7a8d8fc7e3e14e3f1d29
https://doi.org/10.1212/01.wnl.0000801792.09184.e1

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

Autor: Cindy J. Bednasz, Charles S. Venuto, Qing Ma, Eric S. Daar, Paul E. Sax, Margaret A. Fischl, Ann C. Collier, Kimberly Y. Smith, Camlin Tierney, Edward P. Acosta, Donald E. Mager, Gene D. Morse, Hector H. Bolivar, Sandra Navarro, Susan L. Koletar, Diane Gochnour, Edward Seefried, Julie Hoffman, Judith Feinberg, Michelle Saemann, Kristine Patterson, Donna Pittard, David Currin, Kerry Upton, Michael Saag, Graham Ray, Steven Johnson, Bartolo Santos, Connie A. Funk, Michael Morgan, Brenda Jackson, Pablo Tebas, Aleshia Thomas, Ge-Youl Kim, Michael K. Klebert, Jorge L. Santana, Santiago Marrero, Jane Norris, Sandra Valle, Gary Matthew Cox, Martha Silberman, Sadia Shaik, Ruben Lopez, Margie Vasquez, Demetre Daskalakis, Christina Megill, Todd Stroberg, Jessica Shore, Babafemi Taiwo, Mitchell Goldman, Molly Boston, Jeffrey Lennox, Carlos del Rio, Timothy W. Lane, Kim Epperson, Annie Luetkemeyer, Mary Payne, Barbara Gripshover, Dawn Antosh, Jane Reid, Mary Adams, Sheryl S. Storey, Shelia B. Dunaway, Joel Gallant, Ilene Wiggins, Joan A. Swiatek, Joseph Timpone, Princy Kumar, Ardis Moe, Maria Palmer, Jon Gothing, Joanne Delaney, Kim Whitely, Ann Marie Anderson, Scott M. Hammer, Michael T. Yin, Mamta Jain, Tianna Petersen, Roberto Corales, Christine Hurley, Keith Henry, Bette Bordenave, Amanda Youmans, Mary Albrecht, Richard B. Pollard, Abimbola Olusanya, Paul R. Skolnik, Betsy Adams, Karen T. Tashima, Helen Patterson, Michelle Ukwu, Lauren Rogers, Henry H. Balfour, Kathy A. Fox, Susan Swindells, Frances Van Meter, Gregory Robbins, Nicole Burgett-Yandow, Charles E. Davis, Colleen Boyce, William A. O’Brien, Gerianne Casey, Chiu-Bin Hsaio, Jeffrey L. Meier, Jack T. Stapleton, Donna Mildvan, Manuel Revuelta, Wafaa El Sadr, Avelino Loquere, Nyef El-Daher, Tina Johnson, Robert Gross, Kathyrn Maffei, Valery Hughes, Glenn Sturge, Deborah McMahon, Barbara Rutecki, Michael Wulfsohn, Andrew Cheng, Norbert Bischofberger, Lynn Dix, Qiming Liao

Publikováno v: Antimicrobial Agents and Chemotherapy. 63

AIDS Clinical Trial Group study A5202 (ClinicalTrials.gov identifier {"type":"clinical-trial","attrs":{"text":"NCT00118898","term_id":"NCT00118898"}}NCT00118898) was a phase 3b, randomized, partially blinded equivalence study of open-label atazanavir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb699c7a56c4daf00428d4513ced434
https://doi.org/10.1128/aac.01638-18